The Cancer Research Lab (CRL) and CEND (The Center for Emerging and Neglected Diseases) are joining forces to help launch a new campus initiative called the Immunotherapeutics and Vaccine Research Initiative or IVRI. The official launch is on March 24-25, 2016 to coincide with a Symposium on Immunotherapy on the UC Berkeley campus.